【案例名称】Merck & Co.: Evaluating a Drug Licensing Opportunity

【作者】Richard S. Ruback, David Krieger

【页数】6

【格式】PDF

【语言】英语

【出版日期】2000年10月30日

【修订日期】2003年3月25日

【学科】金融 (Finance)

【案例编号】201023-PDF-ENG

【来源】HBS Premier Case Collection

【网页】http://cb.hbsp.harvard.edu/cb/product/201023-PDF-ENG

【简介】

This explores the valuation of an opportunity to license a compound before it enters clinical trials. Describes Merck's decision tree evaluation process is presented. Information required to evaluate a specific licensing opportunity is provided, including the costs of the three phases of the review process, the revenues if approved, and the probability of various outcomes. It includes an introduction to decision tree analysis and valuation.

【学习目标】

To explore decision tree analysis and risk/reward modeling. The primary pedagogical objective is to learn how to build and use decision trees.

【涉及课题】

Capital budgeting; Decision trees; Investments; Present value; Valuation

【背景】

• Industry: Pharmaceuticals
• Company Revenue: $33 billion revenues
• Event Year Begin: 1999
• Event Year End: 1999
  

【下载】

http://www.mbabbs.com/thread-1377-1-1.html